Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of the 5th Sign Intervention on Medication Adherence in Kidney Transplant Recipients: A Randomized Controlled Trial

NCT07851142 is registered in ClinicalTrials.gov with Dokuz Eylul University as lead sponsor.

NCT NCT07851142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07851142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of the 5th Sign Intervention on Medication Adherence in Kidney Transplant Recipients: A Randomized Controlled Trial
Lead sponsor
Dokuz Eylul University
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2024
Completion date
December 31, 2025
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug-related side effects and adverse reactions (mesh term), kidney transplant, medication adherence, mobile applications